Innovative Remote Cardiac Rehabilitation Presentation at the 31st Japanese Congress on Cardiac Rehabilitation

Remote Cardiac Rehabilitation Presentation by Ichihiro Terashima

In a groundbreaking presentation at the 31st Japanese Congress on Cardiac Rehabilitation, held from July 19 to 20, 2025, Ichihiro Terashima, the CEO of CaTe Inc. and an Assistant Professor in the Department of Cardiology at Fujita Health University, took the stage to discuss the use of IoT technology in remote cardiac rehabilitation.

Despite the recognized benefits of cardiac rehabilitation for patients with cardiovascular diseases, implementation and adherence rates remain suboptimal due to factors like the burden of hospital visits and geographical limitations. Furthermore, exercise therapy conducted outside a monitored environment often lacks adequate load adjustment, thereby limiting its effectiveness and safety. Terashima emphasized the need for a more accessible method of delivering cardiac rehabilitation that can be performed at home with proper oversight.

The focus of his lecture, titled "Education Foundation Course 2: Remote Cardiac Rehabilitation Using IoT," was to present the ongoing research and development of medical devices that harness AI and IoT for cardiac rehabilitation. He highlighted that the aim of this innovative program is to provide an environment where patients can successfully engage in rehabilitation from the comfort of their homes.

During his talk, Terashima discussed the potential to improve exercise adherence, enhance exercise tolerance, adopt better lifestyle habits including dietary changes, and ultimately increase the quality of life (QOL) for patients. He stressed that the insights gained from their research could not only benefit patients with cardiovascular diseases but could also be extended to rehabilitation for a wide range of other ailments, improving overall health outcomes.

This symposium served as a platform not only to showcase their findings but also to spark discussion on the future of cardiac rehabilitation through AI and advanced medical devices. As Terashima concluded, the ultimate goal of this initiative is to create a more sustainable and effective rehabilitation program that transcends traditional medical boundaries and reaches patients wherever they may be.

Company Overview

Company Name: CaTe Inc.
CEO: Ichihiro Terashima
Location: Sky Vision Building, 5F, 5-25-13 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
Established: March 18, 2020
Medical Device License: Type 2 Medical Device Manufacturing and Sales Business (13B2X10514)
Website: CaTe Inc.

In addition to Terashima's presentation, other significant announcements were made regarding CaTe Inc.'s successful fundraising efforts. The company raised 1.58 billion yen in Series B financing, further enabling its mission to innovate in the field of remote cardiac rehabilitation.
For those interested in keeping up with the latest at CaTe, additional news includes Terashima's recent accolades at the congress and his leadership role in engaging discussions at the symposium.

This is a pivotal moment in the realm of healthcare technology, especially concerning chronic disease management. As remote and home health interventions expand, the integration of innovative technologies such as AI and IoT will undoubtedly shape the future landscape of cardiac rehabilitation and beyond.